ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Wynzora®:Almirall AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
D05AX52 - Calcipotriol, CombinationsATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D05 - Antipsoriatics
 
D05A - Antipsoriatics for Topical Use

This group comprises products for topical use mainly for the treatment of psoriasis. Corticosteroids for topical use are classified in
D07 - Corticosteroids, dermatological preparations.

D05AX - Other Antipsoriatics for Topical Use

Corticosteroids in combination with vitamin D analogues indicated only for the treatment of psoriasis are classified in D05AX.

D05AX52 - Calcipotriol, Combinations
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home